Ratify (Alliance 10603): Prognostic Impact of FLT3 tyrosine Kinase Domain (TKD) and NPM1 Mutation Status in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Treated with Midostaurin or Placebo Plus Standard Chemotherapy Voso, M., Larson, R. A., Prior, T., Marcucci, G., Jones, D., Krauter, J., Heuser, M., Lavorgna, S., Nomdedeu, J., Geyer, S. M., Klisovic, R., Wei, A. H., Sierra, J., Sanz, M. A., Brandwein, J. M., de Witte, T. M., Jansen, J. H., Niederweiser, D., Appelbaum, F. R., Medeiros, B. C., Tallman, M. S., Schlenk, R. F., Ganser, A., Amadori, S., Cheng, Y., Gathmann, I., Tiecke, E., Thiede, C., Doehner, K., Doehner, H., Stone, R. M., Bloomfield, C. D., Lo-Coco, F. AMER SOC HEMATOLOGY. 2018

View details for DOI 10.1182/blood-2018-99-114318

View details for Web of Science ID 000454837607274